EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of bacteriophage vB_AbaS_SA1 and its synergistic effects with antibiotics against clinical multidrug-resistant Acinetobacter baumannii isolates

Sanaz Rastegar iD, Salehe Sabouri, Omid Tadjrobehkar, Ali Samareh, Hira Niaz, Nafise Sanjari, Hossein Hosseini-Nave, Mikael Skurnik iD

Pathogens and Disease · 2024

DOI: 10.1093/femspd/ftae028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens and Disease, 2024. Verfasst von Sanaz Rastegar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Bacteriophages. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Helsinki, Kerman University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii is a major cause of nosocomial infections globally. The increasing prevalence of multidrug-resistant (MDR) A. baumannii has become an important public health concern. To combat drug resistance, alternative methods such as phage therapy have been suggested. In total, 30 MDR A. baumannii strains were isolated from clinical specimens, and their antibiotic susceptibilities were determined. The Acinetobacter phage vB_AbaS_SA1, isolated from hospital sewage, was characterized. In addition to its plaque size, particle morphology, and host range, its genome sequence was determined and annotated. Finally, the antibacterial effects of phage alone, antibiotics alone, and phage/antibiotic combinations were assessed against the A. baumannii strains. Phage vB_AbaS_SA1 had siphovirus morphology, showed a latent period of 20 min, and a 250 PFU/cell (plaque forming unit/cell) burst size. When combined with antibiotics, vB_AbaS_SA1 (SA1) showed a significant phage-antibiotic synergy effect and reduced the overall effective concentration of antibiotics in time-kill assessments. The genome of SA1 is a linear double-stranded DNA of 50 108 bp in size with a guanine-cytosine (GC) content of 39.15%. Despite the potent antibacterial effect of SA1, it is necessary to perform additional research to completely elucidate the mechanisms of action and potential constraints associated with utilizing this bacteriophage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialBacteriophagesAcinetobacter InfectionsGenome, ViralHost SpecificityHumansMicrobial Sensitivity TestsSewagePhage TherapyDNA, ViralViral Plaque Assay

Stichwörter der Autor:innen

Acinetobacter baumanniibacteriophagedrug resistancesiphovirussynergistic effecttime-kill

Substanzen

Anti-Bacterial AgentsSewageDNA, Viral

Autor:innen und Institutionen

  • Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
  • Department of Medical Microbiology (Bacteriology and Virology), Afzalipour School of Medicine, Kerman, Iran.
  • Extremophile and Productive Microorganisms Research Center, Kerman University of Medical Sciences, Kerman, Iran.
  • Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
  • Department of Biochemistry, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
  • Department of Bacteriology and Immunology, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

ORCID-Profile: Sanaz Rastegar, Mikael Skurnik

Förderung

  • University of Helsinki
  • Kerman University of Medical Sciences

Zitieren

APA

Rastegar, S., Sabouri, S., Tadjrobehkar, O., Samareh, A., Niaz, H., Sanjari, N., Hosseini-Nave, H., & Skurnik, M. (2024). Characterization of bacteriophage vB_AbaS_SA1 and its synergistic effects with antibiotics against clinical multidrug-resistant Acinetobacter baumannii isolates. Pathogens and Disease. https://doi.org/10.1093/femspd/ftae028

Vancouver

Rastegar S, Sabouri S, Tadjrobehkar O, Samareh A, Niaz H, Sanjari N, et al. Characterization of bacteriophage vB_AbaS_SA1 and its synergistic effects with antibiotics against clinical multidrug-resistant Acinetobacter baumannii isolates. Pathogens and Disease. 2024. doi:10.1093/femspd/ftae028

BibTeX
@article{Rastegar2024,
  author = {Rastegar, Sanaz and Sabouri, Salehe and Tadjrobehkar, Omid and Samareh, Ali and Niaz, Hira and Sanjari, Nafise and Hosseini-Nave, Hossein and Skurnik, Mikael},
  title = {Characterization of bacteriophage vB_AbaS_SA1 and its synergistic effects with antibiotics against clinical multidrug-resistant Acinetobacter baumannii isolates},
  journal = {Pathogens and Disease},
  year = {2024},
  doi = {10.1093/femspd/ftae028}
}
Kostenlos starten →